Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 24053678)

1.

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells.

Dupuis ML, Ascione A, Palmisano L, Vella S, Cianfriglia M.

BMC Pharmacol Toxicol. 2013 Sep 20;14:47. doi: 10.1186/2050-6511-14-47.

2.
3.

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein.

Cianfriglia M, Dupuis ML, Molinari A, Verdoliva A, Costi R, Galluzzo CM, Andreotti M, Cara A, Di Santo R, Palmisano L.

Retrovirology. 2007 Mar 7;4:17.

4.

Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.

Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R.

Planta Med. 2006 Jun;72(7):634-9. Epub 2006 May 31.

PMID:
16739070
5.

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S.

Biochemistry. 1998 Mar 17;37(11):3594-601.

PMID:
9530286
6.
7.

Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN.

Biochem Pharmacol. 2002 Aug 15;64(4):573-82.

PMID:
12167476
8.

Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.

Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.

Cancer Chemother Pharmacol. 2005 Aug;56(2):173-81. Epub 2005 Apr 12.

PMID:
15824923
9.
10.

Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors.

Tempestilli M, Gentilotti E, Tommasi C, Nicastri E, Martini F, De Nardo P, Narciso P, Pucillo LP.

Int Immunopharmacol. 2013 Aug;16(4):492-7. doi: 10.1016/j.intimp.2013.05.003. Epub 2013 May 23.

PMID:
23707228
11.

The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.

Ascione A, Cianfriglia M, Dupuis ML, Mallano A, Sau A, Pellizzari Tregno F, Pezzola S, Caccuri AM.

Cancer Chemother Pharmacol. 2009 Jul;64(2):419-24. doi: 10.1007/s00280-009-0960-6. Epub 2009 Mar 15.

PMID:
19288261
12.

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.

Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G.

Cancer Chemother Pharmacol. 1997;40 Suppl:S13-9. Review.

PMID:
9272128
13.

Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.

Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V.

Dalton Trans. 2010 Jul 7;39(25):5842-50. doi: 10.1039/c002361b. Epub 2010 May 27.

PMID:
20505882
14.
15.

Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.

Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.

Biochem Pharmacol. 2006 Sep 28;72(7):824-37. Epub 2006 Aug 4.

PMID:
16889754
16.

PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.

Spitaler M, Utz I, Hilbe W, Hofmann J, Grunicke HH.

Biochem Pharmacol. 1998 Oct 1;56(7):861-9.

PMID:
9774148
17.

Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.

Chaudhary PM, Roninson IB.

J Natl Cancer Inst. 1993 Apr 21;85(8):632-9.

PMID:
8096875
18.

Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.

Muñoz-Martínez F, Lu P, Cortés-Selva F, Pérez-Victoria JM, Jiménez IA, Ravelo AG, Sharom FJ, Gamarro F, Castanys S.

Cancer Res. 2004 Oct 1;64(19):7130-8.

19.

Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.

Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D.

J Nucl Med. 1998 Jan;39(1):77-86.

20.

Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.

Loor F, Tiberghien F, Wenandy T, Didier A, Traber R.

J Med Chem. 2002 Oct 10;45(21):4598-612.

PMID:
12361387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk